Abstract
Leprosy is a chronic granulomatous bacterial infection caused by the bacillus Mycobacterium leprae (M.leprae) that primarily affects the skin and peripheral nerves. Leprosy is a multi-organ infectious disease that can cause severe disability. Lepromatous leprosy is considered to be at the systemic and infectious end of the disease spectrum and correlates with an absence of an immune response to M. leprae antigens. Tuberculoid leprosy form correlates with adequate immune response, lesions are not usually large or numerous and it may resolve spontaneously. Multidrug therapy treatment is a highly effective cure for leprosy. Leprosy may be complicated by episodes of immunological instability including type-1 and type-2 reactions (erythema nodosum leprosum).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Chander R, Jabeen M, Malik M. Molluscum contagiosum-like lesions in histoid leprosy in a 10-year old boy. Pediatr Dermatol. 2013;30:e261–2.
Deps P, Lucas S, Porro AM, et al. Clinical and histological features of leprosy and human immunodeficiency virus co-infection in Brazil. Clin Dermatol. 2013;38:470–7.
Eichenlmann K, Gonzales Gonzales SE, Salas-Alanis JC, Ocampo-Candiani J. Leprosy. An update: definition, pathogenesis, classification, diagnosis and treatment. Actas Dermosifiliogr. 2013;104:554–63.
Grant AV, Cobat A, Van Thuc N, et al. CUBN and NEBL common variants in the chromosome 10p13 linkage region are associated with multibacillary leprosy in Vietnam. Hum Genet. 2014;133(7):883–93. PMID: 24563210.
Hansen GHA. Undersøgelser Angående Spedalskhedens Årsager (investigations concerning the etiology of leprosy). Norsk Mag Laegervidenskaben. 1874;4:1–88.
Jakeman P, Smith WCS. Thalidomide in leprosy reaction. Lancet. 1994;343:432–3.
Kaur I, Dogra S, De D, et al. Histoid leprosy: a retrospective study of 40 cases from India. Br J Dermatol. 2009;160:305–10.
Merle CSC, Cunha SS, Rodrigues LC. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines. 2010;9:209–22.
National Leprosy Elimination Program (NLEP) India. Modified guidelines on MDT regimens to be followed under NLEP. New Delhi: Leprosy Division, Directorate General of Health Services, Ministry of Health and Family Welfare; 1997.
Ridley D, Jopling W. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34:255–73.
Silva GAV, Naveca FG, Ramasawmy R, et al. Association between the IFN-γ +874A/T gene polymorphism and leprosy resistance: a meta-analysis. Cytokine. 2014;65:130–3.
Voorend CGN, Post EB. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. PLoS Negl Trop Dis. 2013;7:e2440.
WHO. Global leprosy situation. Wkly Epidemiol Rec. 2012;87:317–28.
WHO MDT: duration of treatment. http://www.who.int/lep/mdt/duration/en/index1.html. Accessed 1 Apr 2014.
WHO recommended MDT regimens. http://www.who.int/lep/mdt/regimens/en/. Accessed 1 Apr 2014.
WHO. Chemotherapy of leprosy. http://www.who.int/lep/resources/Chemotherapy.pdf?ua=1. Accessed 1 Apr 2014.
WHO. Leprosy today. http://www.who.int/mediacentre/factsheets/fs101/en/. Accessed 1 Apr 2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dessinioti, C., Katsambas, A.D. (2015). Leprosy (Hansen’s Disease). In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_52
Download citation
DOI: https://doi.org/10.1007/978-3-662-45139-7_52
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45138-0
Online ISBN: 978-3-662-45139-7
eBook Packages: MedicineMedicine (R0)